Supplemental Note:
Case Report
Individual 1
Individual 1 was 48 years old at the time of the study. She was born to consanguineous parents, who were half-first cousins once removed, with a fullterm delivery (V-3 of Family 1 in Figure 1A ). She has one affected older sister from whom we could not obtain informed consent for participation in this study.
Her birth weight was 3,300 g. Her motor development milestones were not delayed, except for head control. She had never been able to lift her head up while lying on her back. She had a narrow face and a slender physique. At elementary school, she participated in physical education classes, but consistently performed poorly. She also participated in footraces, but was increasingly far behind her peers. She had never been able to do a pullover on bars, sit-up, or back extension. She could not run up to a balance beam. Pectus excavatum and cardiac hypertrophy were identified at the age of 12. At the age of 25, she had difficulty climbing stairs. At 26, she needed assistance walking up stairs. At 27, she could not stand up independently and was admitted to hospital.
High-arched palate, mildly myopathic face, and generalized muscle weakness with muscle atrophy were noted. Serum creatine kinase was 33 IU/L. A needle electromyogram analysis was carried out showing preserved polyphasic motor unit action potentials, being compatible with myopathic change. A muscle biopsy was performed. Hematoxylin and eosin staining showed variation in fiber size and a decreased number of myofibers with extensive fat replacement and increased connective tissues. In modified Gomori trichrome staining, cytoplasmic bodies and nemaline bodies with a granular shape were observed in the cytoplasm.
Intranuclear rods were also seen, especially in small muscle fibers. Type 1 fiber predominance, which is commonly seen in congenital myopathies, was seen in myosin ATPase staining (data not shown). Based on the biopsied muscle findings, the individual was diagnosed as having nemaline myopathy accompanied by intranuclear rods (Figure 2A and B) . At the age of 29, she could not raise her hands. In her thirties, she could not walk without assistance. Her gait was waddling. At the age of 37, she suffered pulmonary thromboembolism. At 39, she was completely wheelchair-bound. At 40, she could not sit independently. A computed tomography analysis of muscle at the age 46 revealed diffuse atrophy replaced with fat. At 48 years of age, her vital capacity was decreased, although respiratory failure was not observed (VC 1230 ml, %VC 39.9%).
Figure S1. Muscle CT images of individual 4
Muscle CT was performed at different levels at the neck (A), acromion (B), nipple (C), umbilicus (D), symphysis pubis (E), two different levels of thigh (F and G), and calf (H) in individual 4 at the age of 35 years. Atrophy of neck (A), gluteal (E), and femoral (F and G) muscles was particularly noted. Proximaldominant muscle atrophy was seen. Interestingly, in her upper legs, the sartorius, gracilis, biceps brevis femoris muscles were highly degenerated, and mostly replaced with fat tissues. Patchy low-density areas were observed especially in semitendinosus muscles. In contrast, muscles were relatively preserved in her lower legs. Laterality in the muscle atrophy was not observed. cDNA analysis was performed using RNA extracted from the biopsied muscle.
Total RNA was extracted from frozen biopsied muscle using TRIzol Reagent (Thermo Fisher Scientific, Waltham, MA USA) or RNeasy Mini Kit (Qiagen, Hilden, Germany) and reverse-transcribed using SuperScript IV (Thermo Fisher Scientific). Primers for flanking regions of splice site mutations were designed using Primer3 (available on request). The partial cDNA was amplified using PCR Master Mix (Promega, Madison, WI, USA). PCR products were extracted from agarose gel using QIAquick Gel Extraction Kit (Qiagen), and then either directly sequenced or cloned into pCR4 vector using TOPO-TA cloning kit for sequencing 
Figure S11. Palladin protein level in skeletal muscles
The autopsied heart from a control and biopsied muscle from controls (C1 and 2) and individuals 3 (P3) and 4 (P4) were lysed with SDS sample buffer, and then subjected to Western blotting using NuPAGE 3%-8% Tris-Acetate Gel (Thermo Fisher Scientific) in accordance with to the manufacture's protocol. The primary antibodies used were rabbit monoclonal anti-palladin (Abcam) and mouse monoclonal anti-tubulin alpha (DM1A; Sigma-Aldrich). Precision Plus Protein Dual Color Standard (Bio-Rad, Hercules, CA, USA) was used as a protein marker.
Band intensities were quantified with Image J software. Error bars represent standard deviation. Palladin protein level in biopsied muscle was not altered in affected individuals compared to that in the controls.
